Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is a Single Daily Session Combining Hypertonic Saline Nebulisation and Airway Clearance Techniques Sufficient to Obtain Long-term Clinical Benefits in People With Bronchiectasis? A Randomised Non-inferiority Trial.

NCT04905992 is registered in ClinicalTrials.gov with Hospital Clínico Universitario Lozano Blesa as lead sponsor.

NCT NCT04905992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04905992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is a Single Daily Session Combining Hypertonic Saline Nebulisation and Airway Clearance Techniques Sufficient to Obtain Long-term Clinical Benefits in People With Bronchiectasis? A Randomised Non-inferiority Trial.
Lead sponsor
Hospital Clínico Universitario Lozano Blesa
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2021
Completion date
December 31, 2023
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

airway clearance impairment, bronchiectasis